Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 66490-61-7 | MDL No. : | MFCD26743692 |
Formula : | C4H2Br3N3 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | CPWUMNABPMFCEZ-UHFFFAOYSA-N |
M.W : | 331.79 | Pubchem ID : | 20368031 |
Synonyms : |
|
Num. heavy atoms : | 10 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.0 |
Num. rotatable bonds : | 0 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 49.54 |
TPSA : | 51.8 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.54 cm/s |
Log Po/w (iLOGP) : | 1.9 |
Log Po/w (XLOGP3) : | 2.51 |
Log Po/w (WLOGP) : | 2.35 |
Log Po/w (MLOGP) : | 1.31 |
Log Po/w (SILICOS-IT) : | 2.42 |
Consensus Log Po/w : | 2.1 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -3.92 |
Solubility : | 0.0397 mg/ml ; 0.00012 mol/l |
Class : | Soluble |
Log S (Ali) : | -3.24 |
Solubility : | 0.189 mg/ml ; 0.000571 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -3.82 |
Solubility : | 0.05 mg/ml ; 0.000151 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 0.0 |
Synthetic accessibility : | 2.62 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
53% | With sodium sulfide; | EXAMPLE 2 Preparation of 3-Amino-5,6-dibromopyrazinethiol Aminotribromopyrazine was prepared, by the same procedure reported for the trichloro analog, from tetrabromopyrazine. Using the same procedure as above, 30 g. of <strong>[66490-61-7]aminotribromopyrazine</strong>, and 24 g. of sodium sulfide nonohydrate in 500 IPA gave 13.5 g. (53% yield) of the desired compound. Anal. Calcd. for C4 H3 Br2 N3 S: C, 16.86; H, 1.06; N, 14.74. Found: C, 17.55; H, 1.21; N, 14.89. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
87% | With N-Bromosuccinimide; In tetrahydrofuran; at 0 - 21℃; for 12.0833h; | General procedure: [0267] 6-bromopyrazin-2-amine (5.00 g 1.0 equiv.) was dissolved in dry THF (15 mL) at 0 C, NBS (20 g 2.2 equiv.) was added and stirred for 5 min. The reaction was allowed to warm to room temperature and stirred for 12 h. The solvent was evaporated under reduced pressure and the residue was extracted with ethyl acetate and sodium thiosulfate. The organic layer was then washed with water and brine. The combined organic layer was dried over sodium sulfate, filtered and concentrated. The product was purified via silica gel chromatography (ethyl acetate:hexanes). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
57% | With dmap; triethylamine; In dichloromethane; at 21℃; | General procedure: [0268] In a mixture of <strong>[66490-61-7]3,5,6-tribromopyrazin-2-amine</strong> (146 mg, 0.5 mmol), triethylamine (202 mg, 2 mmol), and catalytic amount of DMAP (5 mol %) in dry CH2CI2 (5 mL) was added 3- fluorobenzoylchloride (176 mg, 1 mmol) at room temperature. The mixture was stirred at room temperature overnight, and concentrated under reduced pressure. The residue was then dissolved in MeOH (5 mL) and K2CO3 (100 mg) was added. The mixture was stirred at 60 C for 1 h. The mixture was then reduced down and the product purified via silica chromatography (ethyl acetate:hexanes). |
[ 84539-07-1 ]
3,5-Dibromo-N,N-dimethylpyrazin-2-amine
Similarity: 0.78
[ 84539-07-1 ]
3,5-Dibromo-N,N-dimethylpyrazin-2-amine
Similarity: 0.78
[ 84539-07-1 ]
3,5-Dibromo-N,N-dimethylpyrazin-2-amine
Similarity: 0.78